[
  {
    "ts": null,
    "headline": "Is DexCom Trading Below Fair Value After a 41.8% Three Year Drop?",
    "summary": "Thinking about buying or holding DexCom stock? You’re not alone. Whether you’re a long-term investor or just looking for a timely healthcare pick, DexCom probably caught your attention for its role in continuous glucose monitoring, but its recent price moves might have you wondering if now is the best time to act. Shares closed at $69.23 recently, and the ride has been anything but smooth. In the past seven days, the stock slipped by 0.7%, recovering 3.2% over the last month. Yet DexCom still...",
    "url": "https://finnhub.io/api/news?id=10ad9505322595e78cfe179be54c32acf26b27404749c8957efdd9821f435bad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761761850,
      "headline": "Is DexCom Trading Below Fair Value After a 41.8% Three Year Drop?",
      "id": 137259033,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Thinking about buying or holding DexCom stock? You’re not alone. Whether you’re a long-term investor or just looking for a timely healthcare pick, DexCom probably caught your attention for its role in continuous glucose monitoring, but its recent price moves might have you wondering if now is the best time to act. Shares closed at $69.23 recently, and the ride has been anything but smooth. In the past seven days, the stock slipped by 0.7%, recovering 3.2% over the last month. Yet DexCom still...",
      "url": "https://finnhub.io/api/news?id=10ad9505322595e78cfe179be54c32acf26b27404749c8957efdd9821f435bad"
    }
  },
  {
    "ts": null,
    "headline": "Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics",
    "summary": "Beyond analysts' top-and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.",
    "url": "https://finnhub.io/api/news?id=1a38b9caf5ddc93b08706cb56f3300372b2ebda581e3f7babbc775dcfeb25900",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761743705,
      "headline": "Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics",
      "id": 137259034,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Beyond analysts' top-and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.",
      "url": "https://finnhub.io/api/news?id=1a38b9caf5ddc93b08706cb56f3300372b2ebda581e3f7babbc775dcfeb25900"
    }
  },
  {
    "ts": null,
    "headline": "DexCom (DXCM) Reports Earnings Tomorrow: What To Expect",
    "summary": "Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=22a53a8eae5aad7adaf50e336a1499d3cc3310138be7d9ece098d1a844e444b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761707012,
      "headline": "DexCom (DXCM) Reports Earnings Tomorrow: What To Expect",
      "id": 137242483,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=22a53a8eae5aad7adaf50e336a1499d3cc3310138be7d9ece098d1a844e444b9"
    }
  }
]